Meta-analysis of few small studies in orphan diseases

Abstract

Meta-analyses in orphan diseases and small populations generally face particular problems including small numbers of studies, small study sizes, and heterogeneity of results. However, the heterogeneity is difficult to estimate if only very few studies are included. Motivated by a systematic review in immunosuppression following liver transplantation in children we investigate the properties of a range of commonly used frequentist and Bayesian procedures in extensive simulation studies. Furthermore, the consequences for interval estimation of the common treatment effect in random effects meta-analysis are assessed. The Bayesian credibility intervals using weakly informative priors for the between-trial heterogeneity exhibited coverage probabilities in excess of the nominal level for a range of scenarios considered. However, they tended to be shorter than those obtained by the Knapp-Hartung method, which were also conservative. In contrast, methods based on normal quantiles exhibited coverages well below the nominal levels in many scenarios. With very few studies, the performance of the Bayesian credibility intervals is of course sensitive to the specification of the prior for the between trial heterogeneity. In conclusion, the use of weakly informative priors as exemplified by half-normal priors (with scale 0.5 or 1.0) for log odds ratios is recommended for applications in rare diseases.

23 pages, 6 figures, 3 tables

References in corpus (4)

• Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies
• Bayesian random-effects meta-analysis using the bayesmeta R package
• Meta-analysis of few small studies in orphan diseases
• Interleukin-2 receptor antagonists for pediatric liver transplant recipients: A systematic review and meta-analysis of controlled studies

Cited by in corpus (26)

• Bayesian random-effects meta-analysis using the bayesmeta R package
• Meta-analysis of few small studies in orphan diseases
• On weakly informative prior distributions for the heterogeneity parameter in Bayesian random-effects meta-analysis
• Likelihood-based meta-analysis with few studies: Empirical and simulation studies
• Meta-analysis of two studies in the presence of heterogeneity with applications in rare diseases
• Meta-analysis of few studies involving rare events
• Using the bayesmeta R package for Bayesian random-effects meta-regression
• Dynamically borrowing strength from another study through shrinkage estimation
• Recent advances in methodology for clinical trials in small populations: the InSPiRe project
• Model averaging for robust extrapolation in evidence synthesis
• Discrete approximation of a mixture distribution via restricted divergence
• Using phase II data for the analysis of phase III studies: an application in rare diseases
• Summarizing empirical information on between-study heterogeneity for Bayesian random-effects meta-analysis
• Bounds for the weight of external data in shrinkage estimation
• Alternative to the application of PDG scale factors
• Applying Meta-Analytic-Predictive Priors with the R Bayesian evidence synthesis tools
• How trace plots help interpret meta-analysis results
• Random-effects meta-analysis of phase I dose-finding studies using stochastic process priors
• Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?": A Bayesian perspective
• Subgroup identification in individual patient data meta-analysis using model-based recursive partitioning
• Investigating the heterogeneity of "study twins"
• A confidence interval robust to publication bias for random-effects meta-analysis of few studies
• Bayes Factor Hypothesis Testing in Meta-Analyses: Practical Advantages and Methodological Considerations
• Bayesian random-effects meta-analysis of aggregate data on clinical events
• Shrinkage estimation for dose-response modeling in phase II trials with multiple schedules
• Quantification of empirical determinacy: the impact of likelihood weighting on posterior location and spread in Bayesian meta-analysis estimated with JAGS and INLA